help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenberg, Z.
Right arrow Articles by Bab, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenberg, Z.
Right arrow Articles by Bab, I.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 2330-2335, Copyright © 1995 by Endocrine Society

ARTICLES

Structural and functional characterization of osteogenic growth peptide from human serum: identity with rat and mouse homologs

Z Greenberg, M Chorev, A Muhlrad, A Shteyer, M Namdar-Attar, N Casap, A Tartakovsky, M Vidson and I Bab
Bone Laboratory, Hebrew University of Jerusalem, Israel.

The osteogenic growth peptide (OGP) was recently characterized in regenerating bone marrow. In experimental animals, OGP increases osteogenesis. Immunoreactive OGP (irOGP) in high abundance was demonstrated in normal animal serum mainly as an OGP-OGP-binding protein (OGPBP) complex. Here we show the presence of an OGP-OGPBP system in normal human serum. The total irOGP content, of which the bound peptide comprises at least 80-90%, ranged from 480-4460 mumol/L, several orders of magnitude higher than that of other regulatory polypeptides. The steady state/total irOGP ratio declined between 23 and 49 yr of age. The bound irOGP, purified by boiling, ultrafiltration, and hydrophobic high pressure liquid chromatography, was identical to OGP obtained previously from rat regenerating marrow and mouse stromal cell cultures in terms of its amino acid sequence, immunoreactivity, and mitogenicity. These data demonstrate the usefulness of our immunoassay to measure circulating OGP. More importantly, the identity of the human OGP with that of other species indicates the peptide's evolutionary conservation and, thus, its biological importance. The natural occurrence of OGP in man signifies its potential role in the prevention of bone loss and rescue of bone mass, especially in osteoporosis.


This article has been cited by other articles:


Home page
 Stem CellsHome page
Y. Jung, J. Song, Y. Shiozawa, J. Wang, Z. Wang, B. Williams, A. Havens, A. Schneider, C. Ge, R. T. Franceschi, et al.
Hematopoietic Stem Cells Regulate Mesenchymal Stromal Cell Induction into Osteoblasts Thereby Participating in the Formation of the Stem Cell Niche
Stem Cells, August 1, 2008; 26(8): 2042 - 2051.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Bab, E. Smith, H. Gavish, M. Attar-Namdar, M. Chorev, Y.-C. Chen, A. Muhlrad, M. J. Birnbaum, G. Stein, and B. Frenkel
Biosynthesis of Osteogenic Growth Peptide via Alternative Translational Initiation at AUG85 of Histone H4 mRNA
J. Biol. Chem., May 14, 1999; 274(20): 14474 - 14481.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society